|
1
|
Vtorushin SV, Khristenko KY, Zavyalova MV,
Perelmuter VM, Litviakov NV, Denisov EV, Dulesova AY and
Cherdyntseva NV: The phenomenon of multi-drug resistance in the
treatment of malignant tumors. Exp Oncol. 36:144–156.
2014.PubMed/NCBI
|
|
2
|
Di C and Zhao Y: Multiple drug resistance
due to resistance to stem cells and stem cell treatment progress in
cancer (Review). Exp Ther Med. 9:289–293. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takeishi S and Nakayama KI: To wake up
cancer stem cells, or to let them sleep, that is the question.
Cancer Sci. 107:875–881. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanwar JR, Samarasinghe RM, Kamalapuram SK
and Kanwar RK: Multimodal nanomedicine strategies for targeting
cancer cells as well as cancer stem cell signalling mechanisms.
Mini Rev Med Chem. 17:1688–1695. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Greve B, Kelsch R, Spaniol K, Eich HT and
Götte M: Flow cytometry in cancer stem cell analysis and
separation. Cytometry A. 81:284–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin F, Li HS, Zhao L, Wei YJ, Zhang H, Guo
YJ, Pang R, Jiang XB and Zhao HY: Expression of anti-apoptotic and
multi-drug resistance-associated protein genes in cancer stem cell
isolated from TJ905 glioblastoma multiforme cell line. Zhonghua Yi
Xue Za Zhi. 88:2312–2316. 2008.PubMed/NCBI
|
|
7
|
Asuthkar S, Stepanova V, Lebedeva T,
Holterman AL, Estes N, Cines DB, Rao JS and Gondi CS:
Multifunctional roles of urokinase plasminogen activator (uPA) in
cancer stemness and chemoresistance of pancreatic cancer. Mol Biol
Cell. 24:2620–2632. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin T, Wei H, Gou S, Shi P, Yang Z, Zhao G
and Wang C: Cancer stem-like cells enriched in Panc-1 spheres
possess increased migration ability and resistance to gemcitabine.
Int J Mol Sci. 12:1595–1604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cabang AB, De Mukhopadhyay K, Meyers S,
Morris J, Zimba PV and Wargovich MJ: Therapeutic effects of the
euglenoid ichthyotoxin, euglenophycin, in colon cancer. Oncotarget.
8:104347–104358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang YC, Zhang Y, Zhou J, Zhi Q, Wu MY,
Gong FR, Shen M, Liu L, Tao M, Shen B, et al: Ginsenoside Rg3
targets cancer stem cells and tumor angiogenesis to inhibit
colorectal cancer progression in vivo. Int J Oncol.
52:127–138. 2018.PubMed/NCBI
|
|
11
|
Guo P, Wang S, Liang W, Wang W, Wang H,
Zhao M and Liu X: Salvianolic acid B reverses multidrug resistance
in HCT-8/VCR human colorectal cancer cells by increasing ROS
levels. Mol Med Rep. 15:724–730. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang M, Sun G, Wu P, Chen R, Yao F, Qin M,
Luo Y, Sun H, Zhang Q, Dong X and Sun X: Salvianolic Acid B
prevents arsenic trioxide-induced cardiotoxicity in vivo and
enhances its anticancer activity in vitro. Evid Based Complement
Alternat Med. 2013:7594832013.PubMed/NCBI
|
|
13
|
Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W,
Zhou Y, Pang X, Southerland WM, Califano JA and Gu X: Combination
effects of salvianolic acid B with low-dose celecoxib on inhibition
of head and neck squamous cell carcinoma growth in vitro and in
vivo. Cancer Prev Res (Phila). 3:787–796. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang C, Xie J, Guo J, Manning HC, Gore JC
and Guo N: Evaluation of CD44 and CD133 as cancer stem cell markers
for colorectal cancer. Oncol Rep. 28:1301–1308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin Y, Jiang Z, Guan X, Chen Y, Tang Q,
Wang G and Wang X: miR-450b-5p suppresses stemness and the
development of chemoresistance by targeting SOX2 in colorectal
cancer. DNA Cell Biol. 35:249–256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
An Y and Ongkeko WM: ABCG2: The key to
chemoresistance in cancer stem cells? Expert Opin Drug Metab
Toxicol. 5:1529–1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang W, Stoica G, Tasca SI, Kelly KA and
Meininger CJ: Modulation of tumor angiogenesis by stem cell factor.
Cancer Res. 60:6757–6762. 2000.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang M, Chen DQ, Chen L, Liu D, Zhao H,
Zhang ZH, Vaziri ND, Guo Y, Zhao YY and Cao G: Novel RAS inhibitors
poricoic acid zg and poricoic acid ZH attenuate renal fibrosis via
a Wnt/β-catenin pathway and targeted phosphorylation of smad3
signaling. J Agric Food Chem. 66:1828–1842. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Li L and Wang Y: Effects of Per2
overexpression on growth inhibition and metastasis, and on MTA1,
nm23-H1 and the autophagy-associated PI3K/PKB signaling pathway in
nude mice xenograft models of ovarian cancer. Mol Med Rep.
13:4561–4568. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu X, Shou Q, Chen C, Cai H, Zhang J, Tang
S, Cai B, Tang D and Cao G: An herbal formula attenuates
collagen-induced arthritis via inhibition of JAK2-STAT3 signaling
and regulation of Th17 cells in mice. Oncotarget. 8:44242–44254.
2017.PubMed/NCBI
|
|
22
|
Jin ZJ: Addition in drug combination
(author's transl). Zhongguo Yao Li Xue Bao. 1:70–76. 1980.(In
Chinese). PubMed/NCBI
|
|
23
|
Zhou JY, Chen M, Ma L, Wang X, Chen YG and
Liu SL: Role of CD44(high)/CD133(high) HCT-116 cells in the
tumorigenesis of colon cancer. Oncotarget. 7:7657–7666.
2016.PubMed/NCBI
|
|
24
|
Dou J, Ni Y, He X, Wu D, Li M, Wu S, Zhang
R, Guo M and Zhao F: Decreasing lncRNA HOTAIR expression inhibits
human colorectal cancer stem cells. Am J Transl Res. 8:98–108.
2016.PubMed/NCBI
|
|
25
|
Hasan S, Taha R and Omri HE: Current
opinions on chemoresistance: An overview. Bioinformation. 14:80–85.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okamoto K, Ninomiya I, Ohbatake Y, Hirose
A, Tsukada T, Nakanuma S, Sakai S, Kinoshita J, Makino I, Nakamura
K, et al: Expression status of CD44 and CD133 as a prognostic
marker in esophageal squamous cell carcinoma treated with
neoadjuvant chemotherapy followed by radical esophagectomy. Oncol
Rep. 36:3333–3342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei L, Chen P, Chen Y, Shen A, Chen H, Lin
W, Hong Z, Sferra TJ and Peng J: Pien Tze Huang suppresses the
stem-like side population in colorectal cancer cells. Mol Med Rep.
9:261–266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jia M, Wei Z, Liu P and Zhao X: Silencing
of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in
retinoblastoma cancer stem cells. J Korean Med Sci. 31:836–842.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu J, Li J, Yue X, Wang J, Liu J, Sun L
and Kong D: Expression of the cancer stem cell markers ABCG2 and
OCT-4 in right-sided colon cancer predicts recurrence and poor
outcomes. Oncotarget. 8:28463–28470. 2017.PubMed/NCBI
|
|
30
|
Yanamoto S, Yamada S, Takahashi H, Naruse
T, Matsushita Y, Ikeda H, Shiraishi T, Seki S, Fujita S, Ikeda T,
et al: Expression of the cancer stem cell markers CD44v6 and ABCG2
in tongue cancer: Effect of neoadjuvant chemotherapy on local
recurrence. Int J Oncol. 44:1153–1162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deng L, Li D, Gu W, Liu A and Cheng X:
Formation of spherical cancer stem-like cell colonies with
resistance to chemotherapy drugs in the human malignant fibrous
histiocytoma NMFH-1 cell line. Oncol Lett. 10:3323–3331. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lundberg IV, Edin S, Eklöf V, Öberg Å,
Palmqvist R and Wikberg ML: SOX2 expression is associated with a
cancer stem cell state and down-regulation of CDX2 in colorectal
cancer. BMC Cancer. 16:4712016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chou MY, Hu FW, Yu CH and Yu CC: Sox2
expression involvement in the oncogenicity and radiochemoresistance
of oral cancer stem cells. Oral Oncol. 51:31–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carina V, Zito G, Pizzolanti G, Richiusa
P, Criscimanna A, Rodolico V, Tomasello L, Pitrone M, Arancio W and
Giordano C: Multiple pluripotent stem cell markers in human
anaplastic thyroid cancer: The putative upstream role of SOX2.
Thyroid. 23:829–837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu B, Ma Y, Yang Y, Zhang L, Han H and
Chen J: CD44 promotes cell proliferation in non-small cell lung
cancer. Oncol Lett. 15:5627–5633. 2018.PubMed/NCBI
|
|
36
|
Yan Y, Zuo X and Wei D: Concise review:
Emerging role of CD44 in cancer stem cells: A promising biomarker
and therapeutic target. Stem Cells Transl Med. 4:1033–1043. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bourguignon LY, Shiina M and Li JJ:
Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA
functions, chemoresistance, and radiation resistance in cancer stem
cells leading to tumor progression. Adv Cancer Res. 123:255–275.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim MJ, Koo JE, Han GY, Kim B, Lee YS, Ahn
C and Kim CW: DDual-blocking of PI3K and mTOR improves
chemotherapeutic effects on SW620 human colorectal cancer stem
cells by inducing differentiation. J Korean Med Sci. 31:360–370.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wilson BJ, Schatton T, Frank MH and Frank
NY: Colorectal cancer stem cells: Biology and therapeutic
implications. Curr Colorectal Cancer Rep. 7:128–135. 2011.
View Article : Google Scholar : PubMed/NCBI
|
